IRME 0.35 Stock Price IR-Med Inc.
Range: | 0.33999-1.65 | Vol Avg: | 451 | Last Div: | 0 | Changes: | -0.01 |
Beta: | 1.44 | Cap: | 0.06B | Currency: | USD | Exchange: | PNK |
Sector: | Healthcare | IPO: | Tue Jan 26 2021 | Empoloyees: | 6 |
CUSIP: | | CIK: | 0001839133 | ISIN: | US46265R1032 | Country: | IL |
CEO: | Mr. Ran Ziskind | Website: | https://www.ir-medical.com |
IR-Med Inc., a development stage medical device company, focuses on the development of infra-red light spectroscopy combined with artificial intelligence technology platform to address diagnostic or medical needs. It is developing PressureSafe, a handheld optical monitoring device to support early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear infection (Otitis Media), a common malady in children. The company is headquartered in Rosh Pina, Israel.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.